Zhejiang Haisen Pharmaceutical Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE1000061L9
CNY
25.18
1.66 (7.06%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
173.39
115.50
123.61
118.48
151.47
109.41
94.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
173.39
115.50
123.61
118.48
151.47
109.41
94.84
Raw Material Cost
96.61
63.32
69.52
67.41
89.63
64.60
54.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.09
0.09
0.09
0.08
0.09
0.09
0.09
Selling and Distribution Expenses
17.48
13.65
12.47
8.85
15.51
7.82
10.18
Other Expenses
0.94
0.91
0.75
0.87
0.92
0.55
0.67
Total Expenditure (Excl Depreciation)
123.53
86.18
89.62
85.06
114.46
78.04
71.87
Operating Profit (PBDIT) excl Other Income
49.900000000000006
29.3
34
33.4
37
31.400000000000002
23
Other Income
4.19
2.79
1.96
3.89
9.48
3.12
6.82
Operating Profit (PBDIT)
59.79
38.96
39.33
41.21
46.32
38.05
31.99
Interest
0.09
0.09
0.09
0.08
0.09
0.09
0.09
Exceptional Items
1.70
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
76.79
52.17
54.09
51.07
61.83
44.81
39.91
Depreciation
7.00
7.00
4.94
4.94
4.69
4.69
3.80
Profit Before Tax
54.39
31.87
34.31
36.19
41.53
33.26
28.10
Tax
6.72
4.46
4.72
4.98
5.92
4.35
3.45
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
47.67
27.42
29.58
31.21
35.61
28.91
24.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
47.67
27.42
29.58
31.21
35.61
28.91
24.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
47.67
27.42
29.58
31.21
35.61
28.91
24.66
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,493.76
1,432.17
1,398.38
1,380.54
1,344.15
1,302.97
1,274.14
Earnings per share (EPS)
0.31
0.18
0.09
0.21
0.24
0.19
0.17
Diluted Earnings per share
0.31
0.18
0.09
0.21
0.24
0.19
0.17
Operating Profit Margin (Excl OI)
28.02%
25.26%
26.24%
27.34%
21.22%
27.63%
22.53%
Gross Profit Margin
35.41%
33.66%
31.75%
34.71%
30.52%
34.69%
33.63%
PAT Margin
27.49%
23.74%
23.93%
26.34%
23.51%
26.42%
26.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 14.46% vs 32.55% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 33.99% vs 8.87% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 51.09% vs 4.84% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Zhejiang Haisen Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
173.39
0
173.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
173.39
0
173.39
Raw Material Cost
96.61
0
96.61
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.09
0
0.09
Selling and Distribution Expenses
17.48
0
17.48
Other Expenses
0.94
0.00
0.94
Total Expenditure (Excl Depreciation)
123.53
0
123.53
Operating Profit (PBDIT) excl Other Income
49.87
0.00
49.87
Other Income
4.19
0
4.19
Operating Profit (PBDIT)
59.79
0
59.79
Interest
0.09
0
0.09
Exceptional Items
1.70
0
1.70
Gross Profit (PBDT)
76.79
0
76.79
Depreciation
7.00
0
7.00
Profit Before Tax
54.39
0
54.39
Tax
6.72
0
6.72
Provisions and contingencies
0
0
0.00
Profit After Tax
47.67
0
47.67
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
47.67
0
47.67
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
47.67
0
47.67
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,493.76
0
1,493.76
Earnings per share (EPS)
0.31
0
0.31
Diluted Earnings per share
0.31
0
0.31
Operating Profit Margin (Excl OI)
28.02%
0%
0.00
28.02%
Gross Profit Margin
35.41%
0%
0.00
35.41%
PAT Margin
27.49%
0%
0.00
27.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 17.34 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 50.13% vs -6.55% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 14.46% vs 32.55% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.77 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 74.09% vs -7.43% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 33.99% vs 8.87% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.56 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 53.59% vs -3.21% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 51.09% vs 4.84% in Dec 2024

Quarterly - Interest
Interest 0.01 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.02%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024